Integra LifeSciences Holdings
IARTStock
$19.85+59.97%52W
Market Cap$1.51B
P/E—
Div yield—
Beta1.22
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)33.35%
Price vs S&P 500 (4W)5.44%
VGM Score53.92
Market Capitalization$1.51B
Earnings Surprise History
Q1 260.54est. 0.41
Analyst Recommendations
Mar 2026
Apr 2026
May 2026
Jun 2026
2.71
2.75
2.63
2.73
Industry Peers — Surgical & Medical Instruments(141)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
IARTIntegra LifeSciences Holdings | C | F | A | $19.85 |
| SYKStryker Corporation | C | C | D | $331.20 |
| MMM3M Company | C | F | B | $161.77 |
| BSXBoston Scientific Corp. | C | B | F | $44.62 |
| MDLNMedline Inc. Class A common stock | C | D | D | $41.11 |
| BDXBecton, Dickinson and Co. | B | C | B | $159.93 |
| DXCMDexCom, Inc. | C | B | C | $77.98 |
| RMDResMed Inc. | C | B | D | $202.76 |
| WSTWest Pharmaceutical Services, Inc. | D | C | A | $362.44 |
| SOLVSolventum Corporation | C | D | B | $81.70 |
| PENPenumbra, Inc. | F | C | B | $319.60 |
About
Integra Lifesciences Holdings Corp is a New Jersey-based medical devices company specializing in regenerative therapy, extremity orthopedics, and neurosurgical solutions. The company operates through two main segments—Codman Specialty Surgical, which generates the majority of revenue, and Tissue Technologies—with a global presence spanning North America, Europe, and Asia Pacific, supported by substantial U.S. market sales.